Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on July 17, 2026 by admin

Evaluation of Foquest in Adults 65 Years and Older With ADHD

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Drug: Methylphenidate hydrochloride extended-release capsules

Sponsors: Dar Clinical Research Inc.

Not yet recruiting
CategoriesClinicalTrials.gov TagsAcademic research, ADHD, Cognitive focus and executive control, News Approved

Post navigation

Previous PostPrevious Modular Antibody–ADC Click Chemistry Overcomes Tumor Drug Resistance in Mice
Next PostNext Prevalence of Depression Among Patients With Alopecia Areata
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.